Skip to main navigation

Immunocore

Immunocore

Primary Menu

  • Overview
  • News & Events
    • News Releases
    • Events
    • Presentations
  • Stock Information
    • Stock Quote & Chart
    • Analysts Coverage
  • Corporate Governance
    • Document & Charters
    • Management Team
    • Board of Directors
    • Committee Composition
  • Financials & Filings
    • SEC Filings
    • Annual Reports
  • IR Resources
    • FAQs
    • Email Alerts
    • Contact Us

Primary Menu

  • Overview
  • News & Events
    • News Releases
    • Events
    • Presentations
  • Stock Information
    • Stock Quote & Chart
    • Analysts Coverage
  • Corporate Governance
    • Document & Charters
    • Management Team
    • Board of Directors
    • Committee Composition
  • Financials & Filings
    • SEC Filings
    • Annual Reports
  • IR Resources
    • FAQs
    • Email Alerts
    • Contact Us

News Releases

Breadcrumb

  1. Home /
  2. Investor Relations /
  3. News & Events /
  4. News Releases
9 December 2010
First-in-class exposure in man
9 November 2010
Grand Challenges Explorations Award for HIV
5 October 2010
Clinical trials commence for melanoma in UK and USA
1 February 2010
Dr Jonathan Knowles joins the Board
5 December 2009
Immunocore and Cardiff University refine smart weapons for cancer
1 October 2008
Immunocore Limited Founded

Pagination

  • First page « first
  • Previous page ‹ previous
  • …
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Current page 14
Displaying 131 - 136 of 136

Site - Shareholder Tools

Print Page
Email Alerts
RSS Feeds
Email Page

Immunocore

Immunocore

Site - Footer Social

  • About us
  • Our science
  • Our therapy areas
  • For patients
  • News
  • Careers
  • Contact us
  • Privacy and Social Media Guidelines
  • Cookies
  • Payments and Disclosures
  • Clinical trials

©2022 Immunocore, Ltd. All rights reserved. ImmTAC, ImmTAV, ImmTAB, ImmTAAI and ImmTAX are all registered trademarks of Immunocore, Ltd